文章摘要
Xiaoying Quan,Pinjia Wang,Lei Lei,Xiaoyan Chen,Chunzhi Wu,Bin Ye,Zhihui Zhang. Analysis of clinical efficacy of P-Gemox regimen sandwich radiotherapy, P-Gemox regimen sequential radiotherapy, and radiotherapy alone treatment for extranodal natural killer/T-cell lymphoma. Oncol Transl Med, 2018, 4: 185-195.
P-Gemox夹心放疗,P-Gemox序贯放疗以及单纯放疗治疗结外NK/T细胞淋巴瘤的疗效分析
Analysis of clinical efficacy of P-Gemox regimen sandwich radiotherapy, P-Gemox regimen sequential radiotherapy, and radiotherapy alone treatment for extranodal natural killer/T-cell lymphoma
Received:September 30, 2018  Revised:November 16, 2018
DOI:10.1007/s10330-018-0304-4
中文关键词: 培门冬酶;结外NK/T细胞淋巴瘤;预后
英文关键词: pegaspargase; natural killer/T-cell lymphoma; prognosis
基金项目:四川省卫生厅科学研究项目(编号:090528)
Author NameAffiliationE-mail
Xiaoying Quan Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China 1193084163@qq.com 
Pinjia Wang Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China  
Lei Lei Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China  
Xiaoyan Chen Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China  
Chunzhi Wu Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China  
Bin Ye Department of Medical Oncology, The Sixth People's Hospital of Chengdu, Chengdu 610051, China  
Zhihui Zhang* Department of Medical Oncology, Sichuan Cancer Hospital and Research Institute, Chengdu 610041, China 13881889731@139.com 
Hits: 8419
Download times: 9797
中文摘要:
  目的:探讨P-Gemox夹心放疗,P-Gemox序贯放疗以及单纯放疗治疗结外NK/T细胞淋巴瘤的疗效。方法:回顾性分析2009年6月~2016年1月初治的124例早期结外NK/T细胞淋巴瘤患者的临床资料,比较三种治疗模式的临床疗效。结果:46例患者选择P-Gemox夹心放疗,CR为91.3%,ORR为97.8%,2年PFS为76.1%,2年OS为80.4%。37例患者采用P-Gemox方案序贯放疗,CR为86.5%,ORR为94.6%,2年PFS为75.7%,2年OS为81.1%。41例患者行单纯放疗,CR为61.0%,ORR为80.5%,2年PFS为51.2%,2年OS为65.9%。两两比较显示,单纯放疗与夹心放疗组,序贯放疗组的CR,PFS和OS比较差异均有统计学意义(P<0.05)。但是,夹心放疗组与序贯放疗组的CR,ORR,PFS,OS差异无统计学意义(P>0.05)。多因素分析显示:ECOG,LDH,血小板淋巴细胞比值(platelet to lymphocyte ratio, PLR),局部肿瘤浸润及治疗模式是影响PFS的独立预后因素(P<0.05)。而ECOG,LDH,PLR,局部肿瘤浸润,合并基础疾病及治疗模式是影响OS的独立预后因素(P<0.05)。结论: P-Gemox化疗方案联合放疗治疗早期结外NK/T细胞淋巴瘤优于单纯放疗。
英文摘要:
    Objective The study aimed to explore the clinical efficacy of P-Gemox regimen sandwich radiotherapy, P-Gemox regimen sequential radiotherapy, and radiotherapy alone in early-stage extranodal natural killer/ T-cell lymphoma (ENKTL). Methods In total, 124 patients with early-stage ENKTL, from June 2009 to January 2016, were retrospectively analyzed to compare the clinical efficacy of the three regimens. Results A total of 46 patients were treated with P-Gemox regimen sandwich radiotherapy, with complete remission (CR) of 91.3%, objective response rate (ORR) of 97.8%, 2-year progression-free survival (PFS) of 76.1%, and 2-year overall survival (OS) of 80.4%. Then, 37 patients received P-Gemox regimen sequential radiotherapy, with CR of 86.5%, ORR of 94.6%, 2-year PFS of 75.7%, and 2-year OS of 81.1%. Finally, 41 patients received radiotherapy alone, with CR of 61.0%, ORR of 80.5%, 2-year PFS of 51.2%, and 2-year OS of 65.9%. When the two groups were compared, significant differences in CR, PFS, and OS were observed among the sandwich radiotherapy, sequential radiotherapy, and radiotherapy alone groups (P < 0.05), respectively. However, no significant difference in CR, ORR, PFS, and OS was observed between the sandwich radiotherapy and sequential radiotherapy groups (P > 0.05). Multivariate analysis revealed that Eastern Cooperative Oncology Group (ECOG), serum lactate dehydrogenase (LDH), plateletto-lymphocyte ratio (PLR), local tumor invasion, and treatment modalities were independent prognostic factors for PFS (P < 0.05). ECOG, LDH, PLR, local tumor invasion, underlying disease, and treatment modalities were independent prognostic factors for OS (P < 0.05). Conclusion P-Gemox regimen combination radiotherapy for patients with early-stage ENKTL was better than the radiotherapy alone.
View Full Text   Download reader  HTML全文
Close